Investor information (TSXV:KSI)

2019 Investor News

• December 11, 2019 | Kneat Signs Global Biopharma Leader Read More
• November 26, 2019 | Kneat Reports Third Quarter Results Read More
• November 25, 2019 | Big Pharma selects Kneat’s SaaS Platform for Digitalization of its Validation Work Processes Read More
• September 20, 2019 | Kneat Appoints New Chief Financial Officer Read More
• September 17, 2019 | Big Pharma selects Kneat’s Commissioning, Qualification and Validation platform Read More
• August 27, 2019 | Kneat Reports Second Quarter Results Read More
• July 22, 2019 | Global CDMO partners with Kneat to Digitize their Validation work Processes Read More
• June 17, 2019 | Pioneering Biotech selects Kneat for its Validation Life Cycle Management Read More
• June 11, 2019 | Kneat to Provide Corporate Update via Webcast on June 19, 2019 Read More
• May 28, 2019 | Kneat Reports First Quarter Results Read More
• May 1, 2019 | Kneat Appoints SaaS Industry Veteran, Rory Cameron, as New Board Member Read More
• April 24, 2019 | Kneat Reports Fourth Quarter Results Read More
• April 11, 2019 | Kneat to Present at Bloom Burton & Co. Healthcare Investor Conference Read More
• March 11, 2019 | Kneat Signs Global Biotechnology Leader Read More
• March 07, 2019 | Kneat Announces Grant of Stock Options Read More
• February 21, 2019 | Kneat and HCL Technologies Partner to Deliver Digital Validation Solutions to Life Sciences Read More
• February 20, 2019 | Kneat closes equity financings totalling over $8.5M Read More
• February 14, 2019 | Recently Signed Customer Scales Kneat’s platform to Second Site Read More
• February 13, 2019 | Kneat announces customer expansion at flagship US site and provides financing update Read More
• February 07, 2019 | Kneat Announces Overnight Marketed Equity Financing Read More